Danaher to acquire GE Biopharma for $21.4 billion

Danaher Corporation announced a definitive agreement to acquire the Biopharma business of GE Life Sciences for approximately $21.4 billion in cash, with a net purchase price of about $20 billion after tax benefits.

“Danaher Corporation announced today that it has entered into a definitive agreement with General Electric Company to acquire the Biopharma business of GE Life Sciences for a cash purchase price of approximately $21.4 billion.”prnewswire.com

• 2 sources
• prnewswire.comDanaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 BillionDanaher CorporationFeb 25, 2019
• bloomberg.comGE Jumps as $21.4 Billion Bio-Pharma Sale Lifts New CEO’s Revamp - BloombergRick CloughFeb 25, 2019

Summarized from public sources; check the original articles before acting on it.